1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,745 | 0,781 | 13:04 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.05. | Nanoform Finland Oyj: Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology | 597 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | May 19, 2026 at 08:10:00 EEST
Record first quarter revenue, income and gross margin. Revenue grew by 45%, gross margin reached 94% and operating costs fell by... ► Artikel lesen | |
| 12.05. | Nanoform Finland Oyj: Inside information: Nanoform Signs First Exclusivity Agreement for Ultra-High Concentration Subcutaneous Delivery | 681 | GlobeNewswire (Europe) | Nanoform Finland Plc | Inside Information | May 12, 2026 at 08:00:00 EEST
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it has... ► Artikel lesen | |
| 21.04. | Nanoform Finland Oyj: Resolutions of Nanoform Finland Plc's Annual General Meeting on April 21, 2026 | 537 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | April 21, 2026 at 12:20:00 EEST
Nanoform Finland Plc (the "Company" or "Nanoform") held its Annual General Meeting for 2026 on April 21, 2026 at the Company's... ► Artikel lesen | |
| 02.03. | Nanoform Finland Oyj: The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees | 820 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | March 02, 2026 at 08:10:00 EET
Helsinki, Finland - The Annual General Meeting of Nanoform Finland Plc ("Nanoform") has on 15 April 2025 authorized the company's... ► Artikel lesen | |
| 26.02. | Nanoform Finland Oyj: Nanoform Q4 & FY2025 report - Next: the submission of a marketing authorization application for Nanoenzalutamide in Europe | 772 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | February 26, 2026 at 08:10:00 EET
Product kernel strategy continues to gain traction. Nanoenzalutamide: pivotal human fed and fasted study concluded, three more... ► Artikel lesen | |
| NANOFORM FINLAND Aktie jetzt für 0€ handeln | |||||
| 07.01. | Nanoform Finland Oyj: Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030 | 773 | GlobeNewswire (Europe) | Nanoform Finland Plc | Inside Information | January 07, 2026 at 08:05:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform") starts change negotiations in accordance with the Act on Cooperation.... ► Artikel lesen | |
| 16.12.25 | Nanoform Finland Oyj: Inside information: Nanoform announces new midterm business targets for 2030 | 1.524 | GlobeNewswire (Europe) | Nanoform Finland Plc | Inside Information | December 16, 2025 at 07:00:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced new midterm... ► Artikel lesen | |
| 12.11.25 | Nanoform Finland Oyj: Nanoform Q3 report: Momentum in kernels continues, commercial cGMP manufacturing license received, first near-term target for 2026 set | 1.824 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET
Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and... ► Artikel lesen | |
| 11.11.25 | Nanoform Finland Oyj: Inside information made public: Nanoform Granted European Commercial cGMP Manufacturing License | 839 | GlobeNewswire (Europe) | Nanoform Finland Plc | Inside Information | November 11, 2025 at 08:00:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that... ► Artikel lesen | |
| 27.10.25 | Nanoform Finland Oyj: Nanoform Partners With Revio Therapeutics To Develop Long-Acting Locally-Delivered Hydrogel Nanoformulation To Treat Glioma | 955 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | October 27, 2025 at 09:10:00 EET
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced a partnership... ► Artikel lesen | |
| 14.10.25 | Nanoform Finland Oyj: Nanoform Outlicenses Nanoencorafenib And Signs Development And Commercialisation Agreement With A.forall And IMGA | 980 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | October 14, 2025 at 09:30:00 EEST
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it has... ► Artikel lesen | |
| 30.09.25 | Nanoform Finland Oyj: Nanoform Expands Commercial Presence In Asia With A&ls Pharma In South Korea | 994 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | September 30, 2025 at 09:30:00 EEST
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced it has entered... ► Artikel lesen | |
| 21.08.25 | Nanoform Finland Oyj: Nanoform Q2 2025 report: Continued progress on many fronts, supportive first preliminary pivotal nanoenzalutamide study results | 1.820 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | August 21, 2025 at 08:10:00 EEST
First preliminary pivotal study results supportive for project Nanoenzalutamide to continue to progress towards the markets.... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,120 | -2,85 % | Was Insider bei Formycon zum Wochenstart bereits wissen: Was hinter dem Kursanstieg wirklich steckt - Meine Strategie für die kommende Handelswoche! | ||
| VEECO INSTRUMENTS | 51,14 | 0,00 % | Veeco Instruments Inc.: Veeco Announces $250 Million+ in Equipment Orders for Manufacturing Indium Phosphide Lasers | High-volume orders from multiple customers for its Spector, Lumina and Wet Processing Systems to drive strong growth. PLAINVIEW, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ:... ► Artikel lesen | |
| ONTO INNOVATION | 277,40 | +0,95 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| XTPL | 16,480 | +12,72 % | EQS-News: XTPL S.A.: XTPL advances to the next stage of industrial evaluation and is to deliver a DPS device to a new partner in Japan | Issuer: XTPL S.A.
/ Key word(s): Incoming Orders/Contract
XTPL advances to the next stage of industrial evaluation and is to deliver a DPS device to a new partner in Japan
03.07.2026... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,205 | +1,49 % | SMOLTEK NANOTECH HOLDING AB: Smoltek's share now available for trading also in Germany and the US | ||
| RIBER | 11,220 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 19.06.2026 | Das Instrument 5DP NO0013711739 DOLPHIN DRILL.A.S. NK 2,5 EQUITY wird ex Kapitalmassnahme gehandelt am 19.06.2026 The instrument 5DP NO0013711739 DOLPHIN DRILL.A.S. NK 2,5 EQUITY is traded ex capital... ► Artikel lesen | |
| KOPIN | 3,529 | +1,32 % | Kopin Secures Multiple Orders For Sentinel FPV In U.S. OWA Drone Initiative | ||
| ZENTEK | 0,438 | +4,29 % | Zentek Ltd.: Zentek Establishes Pathway to Sell ZenGUARD Enhanced Air Filtration Media in the U.S. | Guelph, Ontario--(Newsfile Corp. - June 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") announces it has secured a pathway to sell ZenGUARD Enhanced Air Filtration... ► Artikel lesen | |
| DOTZ NANO | 0,020 | +5,38 % | DOTZ NANO LIMITED: Investor Presentation | ||
| OBDUCAT | 0,045 | 0,00 % | NGM MARKET NOTICE: #26-16 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Obducat AB | ||
| ACACIA RESEARCH | 3,880 | -3,96 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| NVE | 85,50 | 0,00 % | Dividendenbekanntmachungen (18.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2A SPA IT0001233417 - 0,104 EUR AIR LIQUIDE SA FR0000120073 - 3,7 EUR ALCOA CORPORATION CDIS AU0000339426 0,1 USD 0,086 EUR ALLISON... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,424 | +0,47 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LAMPETIA | 0,100 | -20,00 % | EQS-Adhoc: Lampetia AG: Lampetia hebt Gewinnprognose für das laufende Geschäftsjahr deutlich an | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Prognose / Gesamtjahr
Lampetia AG hebt Gewinnprognose für das laufende Geschäftsjahr deutlich an
01.07.2026 / 19:30 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| GOMSPACE | 1,347 | 0,00 % | GomSpace A/S: GomSpace Signs 24.4 MSEK Contract with Unseenlabs | Unseenlabs extends its existing cube satellites constellation.STOCKHOLM, July 1, 2026 /PRNewswire/ -- Today, GomSpace has signed an additional contract with Unseenlabs to deliver two new... ► Artikel lesen |
Das Unternehmen NANOFORM FINLAND OYJ kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,45 % bei einem Aktienkurs von 0,749 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOFORM FINLAND OYJ finden Sie auf Wallstreet Online.